← Leaderboards
Amit Choudhary
Broad Institute, Inc.
$8,194,699
Attributed
$17,878,367
Total exposure
13
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2016–25$5M$3.8M$2.5M$1.3M$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$17,878,367 · 13
By mechanism
R01$8,484,274 · 5
U01$4,397,387 · 2
UC4$2,696,088 · 1
R21$2,300,618 · 5
Top collaborators
- Rohit N. Kulkarni11 shared
- Bridget K Wagner8 shared
- Stephen M Secor5 shared
- Ronald T Raines4 shared
- James Anthony Walker4 shared
- Neal Krishna Devaraj3 shared
- Jeffrey Michael Karp3 shared
- Omar Sultan Akbari2 shared
Others in their field
Top investigators on “Small Molecule”
- David Heimbrook · Leidos Biomedical Research, Inc.$251,072,489
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Peter C Adamson · National Childhood Cancer Foundation$143,645,434
- Mark S Klempner · Tufts Medical Center$128,021,180
- Stuart L Schreiber · Harvard University (Medical School)$79,067,419
- Edward A Dennis · University Of California, San Diego$73,030,813
Research focus
Small MoleculeCellsBaseBindingSpecificityComplexProteinsScreeningDoseInsulin-Dependent Diabetes MellitusBeta CellTechnologyInsulinClustered Regularly Interspaced Short Palindromic RepeatsBiologyGuide RnaProdrugsAffinityCrispr/Cas TechnologyMediatingLaboratoriesReportingCell SurvivalExhibits
Grant awards (34)
Development of platforms for beta cell-specific delivery and ligand discovery$931,590
U01 · FY2025 · DK · contact PI
Development of platforms for sorting, production, editing of beta cells$651,811
R01 · FY2025 · DK · contact PI
Development of antimicrobials based on principles of induced proximity$481,250
R21 · FY2025 · AI · contact PI
Development of phosphorylation editing chimeras using kinase inhibitors$210,000
R21 · FY2025 · AI · contact PI
Development of platforms for beta cell-specific delivery and ligand discovery$962,401
U01 · FY2024 · DK · contact PI
Development of platforms for sorting, production, editing of beta cells$623,544
R01 · FY2024 · DK · contact PI
Interrogating the ubiquitin pathway to understand and treat cytokine-induced beta-cell death in type 1 diabetes$512,291
R01 · FY2024 · DK · contact PI
Chemical approaches for precision genome editing$362,632
R01 · FY2024 · GM · contact PI
Development of phosphorylation editing chimeras using kinase inhibitors$252,000
R21 · FY2024 · AI · contact PI
Development of platforms for beta cell-specific delivery and ligand discovery$943,657
U01 · FY2023 · DK · contact PI
Development of platforms for sorting, production, editing of beta cells$691,470
R01 · FY2023 · DK · contact PI
Interrogating the ubiquitin pathway to understand and treat cytokine-induced beta-cell death in type 1 diabetes$542,971
R01 · FY2023 · DK · contact PI
Chemical approaches for precision genome editing$362,632
R01 · FY2023 · GM · contact PI
Development of synthetic gene drives using small molecules$357,272
R01 · FY2022 · GM · contact PI
Chemical approaches for precision genome editing$352,551
R01 · FY2022 · GM · contact PI
A general, virus-free platform to rapidly map SARS-CoV-2 drug resistance$195,000
R21 · FY2022 · AI · contact PI
Development of synthetic gene drives using small molecules$357,344
R01 · FY2021 · GM · contact PI
Chemical approaches for precision genome editing$347,463
R01 · FY2021 · GM · contact PI
A general, virus-free platform to rapidly map SARS-CoV-2 drug resistance$234,243
R21 · FY2021 · AI · contact PI
Development of phosphorylation-inducing chimeric small molecules$200,000
R21 · FY2021 · AI · contact PI
Chemical approaches for precision genome editing$74,047
R01 · FY2021 · GM · contact PI
One-compound, one-islet: A high-throughput platform for small-molecule discovery$765,531
U01 · FY2020 · DK
Leveraging snakes' extreme physiology to modulate human beta-cell function$461,308
R01 · FY2020 · DK · contact PI
Development of synthetic gene drives using small molecules$337,064
R01 · FY2020 · GM · contact PI
Development of phosphorylation-inducing chimeric small molecules$240,000
R21 · FY2020 · AI · contact PI
One-compound, one-islet: A high-throughput platform for small-molecule discovery$794,208
U01 · FY2019 · DK
Leveraging snakes' extreme physiology to modulate human beta-cell function$520,785
R01 · FY2019 · DK · contact PI
Development of synthetic gene drives using small molecules$377,483
R01 · FY2019 · GM · contact PI
Leveraging snakes' extreme physiology to modulate human beta-cell function$528,239
R01 · FY2018 · DK · contact PI
Development of small molecule-based methods for targeted cargo delivery to beta cells$2,696,088
UC4 · FY2017 · DK · contact PI
Leveraging snakes' extreme physiology to modulate human beta-cell function$528,239
R01 · FY2017 · DK · contact PI
Identification of potent small molecule inhibitors of Cas9$221,875
R21 · FY2017 · AI · contact PI
Leveraging snakes' extreme physiology to modulate human beta-cell function$495,128
R01 · FY2016 · DK · contact PI
Identification of potent small molecule inhibitors of Cas9$266,250
R21 · FY2016 · AI · contact PI